Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 3;15(8):e42911.
doi: 10.7759/cureus.42911. eCollection 2023 Aug.

Gender Disparities in Prolactinomas: Unravelling Clinical Patterns, Metabolic Variations, and Treatment Responses

Mohammad Salem Baba  1 , Sajad Ul Islam Mir  2 , Moomin Hussain Bhat  3 , Bashir Ahmad Laway  3 , Raiz Ahmad Misgar  3
Affiliations

Gender Disparities in Prolactinomas: Unravelling Clinical Patterns, Metabolic Variations, and Treatment Responses

Mohammad Salem Baba et al. Cureus. .

Abstract

Background and objective Individuals with prolactinoma exhibit elevated rates of obesity, metabolic syndrome (MS), and dyslipidemia compared to their healthy counterparts. However, there is a lack of data regarding metabolic variance between male and female prolactinoma patients. Consequently, this study aimed to investigate and compare sex-specific discrepancies in metabolic abnormalities among individuals diagnosed with prolactinoma. Methods In this prospective study, 80 treatment-naïve patients with prolactinoma (12 males and 68 females) underwent clinical assessments and laboratory investigations. The measured parameters included blood glucose, total cholesterol (TC), triglycerides (TG), LDL cholesterol (LDL-C), HDL cholesterol (HDL-C), urea, creatinine, uric acid, and blood glucose levels. The patients were treated with cabergoline, a dopamine agonist, and reevaluated after 12 weeks. Results Forty-eight patients had microprolactinomas (all females), and 32 had macroprolactinomas (20 females, 12 males). The mean age was 28.30±7.49 years for females and 28.91±7.12 years for males (p=0.71). The median symptom duration was 12 months (range 1-72 months, IQR 4-16 months), with no significant difference between males (median 12 months, IQR 5-54 months) and females (median 12 months, IQR 10-24 months, p=0.620). The median serum prolactin (PRL) was 988 ng/mL (IQR 471-1,439) in males and 165 ng/mL (IQR 90-425) in females (p<0.05). Males showed higher HbA1c, BGF, TC, TG, LDL-C, and higher rates of obesity, MS, and diabetes mellitus. Treatment with cabergoline resulted in significant improvements in the HbA1c, BGF, TC, TG, and LDL-C levels. Conclusion Males with prolactinomas had larger tumor sizes and higher serum PRL levels than females. Additionally, males exhibited worse metabolic parameters than females. However, there was no significant difference in the duration of symptoms or age at diagnosis between the two groups.

Keywords: hyperprolactinemia; metabolic syndrome; pituitary gland; prolactin levels; prolactinoma.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

See all similar articles

References

    1. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK) Fernandez A, Karavitaki N, Wass JA. Clin Endocrinol (Oxf) 2010;72:377–382. - PubMed
    1. A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas. Sant' Anna BG, Musolino NR, Gadelha MR, et al. Pituitary. 2020;23:120–128. - PubMed
    1. Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience. Anagnostis P, Adamidou F, Polyzos SA, Efstathiadou Z, Karathanassi E, Kita M. Pituitary. 2012;15:25–29. - PubMed
    1. Gender-related differences in prolactin secretion in pituitary prolactinomas. Nishioka H, Haraoka J, Akada K, Azuma S. Neuroradiology. 2002;44:407–410. - PubMed
    1. Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference. Kreutz J, Vroonen L, Cattin F, et al. Neuroradiology. 2015;57:679–684. - PubMed

LinkOut - more resources